Skip to main content
OpenTrials

Clinical trial condition

Sexually Transmitted Diseases, Viral

Explore clinical trials studying Sexually Transmitted Diseases, Viral. Study availability and eligibility vary by location and protocol.

6,138 public trials 362 recruiting studies
Refine in advanced search Browse all conditions

Sexually Transmitted Diseases, Viral trial results

Completed

A Multi-Center Clinical Trial To Evaluate Azidothymidine (AZT) in the Treatment of Human Immunodeficiency Virus (HIV) Infection in Patients With AIDS Post First Episode PCP

NCT00000700

Conditions
AIDS-Related Opportunistic Infections, Acquired Immunodeficiency Syndrome, Bacterial Infections and Mycoses, +24 more
Locations
  • Los Angeles County - USC Med Ctr Los Angeles, California, United States
  • UCLA CARE Ctr Los Angeles, California, United States
  • Univ of California / San Diego Treatment Ctr San Diego, California, United States
  • San Francisco AIDS Clinic / San Francisco Gen Hosp San Francisco, California, United States
View all 28 locations
View Trial Details
Completed

A Phase I Comparative Blinded Trial of Several HIV-1 Derived Immunogens in Infected Individuals With >= 500 CD4 Cells/mm3

NCT00000779

Conditions
AIDS-Related Complex, Blood-Borne Infections, Communicable Diseases, +13 more
Locations
  • UCLA CARE Center CRS Los Angeles, California, United States
  • Stanford CRS Palo Alto, California, United States
  • Santa Clara Valley Med. Ctr. San Jose, California, United States
  • San Mateo County AIDS Program San Mateo, California, United States
View Trial Details
Completed

Comparison of Foscarnet Versus Vidarabine in the Treatment of Herpes Infection in Patients With AIDS Who Have Not Had Success With Acyclovir

NCT00000985

Conditions
Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +20 more
Locations
  • Rush Univ. Med. Ctr. ACTG CRS Chicago, Illinois, United States
  • Beth Israel Deaconess - East Campus A0102 CRS Boston, Massachusetts, United States
  • Univ. of Rochester ACTG CRS Rochester, New York, United States
  • University of Washington AIDS CRS Seattle, Washington, United States
View Trial Details
Completed

Treatment With Combinations of Several Antiviral Drugs in Infants and Young Children With HIV Infection

NCT00000872

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • Univ. of Florida College of Medicine-Dept of Peds, Div. of Immunology, Infectious Diseases & Allergy Gainesville, Florida, United States
  • Tulane/LSU Maternal/Child CRS New Orleans, Louisiana, United States
  • Univ. of Maryland Med. Ctr., Div. of Ped. Immunology & Rheumatology Baltimore, Maryland, United States
  • Johns Hopkins Hosp. & Health System - Dept. of Peds., Div. of Infectious Diseases Baltimore, Maryland, United States
View Trial Details
Completed

A Phase I, Multicenter, Randomized, Double-Blind, Placebo-Controlled HIV-1 Vaccine Trial to Evaluate the Safety and Immunogenicity of MN Recombinant Soluble gp120/HIV-1 (rsgp120/HIV-1) (Genentech) in Combination With QS21 Adjuvant and/or Alum in Healthy Adults

NCT00001052

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • St. Louis Univ. School of Medicine AVEG St Louis, Missouri, United States
  • Univ. of Rochester AVEG Rochester, New York, United States
  • JHU AVEG Pittsburgh, Pennsylvania, United States
  • Vanderbilt Univ. Hosp. AVEG Nashville, Tennessee, United States
View Trial Details
Completed

Nitazoxanide Plus Ribavirin and Peginterferon for Therapy of Treatment Naive HCV Genotype 1 and HIV Coinfected Subjects

NCT00991289

Conditions
Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +19 more
Locations
  • Alabama Therapeutics CRS Birmingham, Alabama, United States
  • UCLA CARE Center CRS Los Angeles, California, United States
  • Stanford AIDS Clinical Trials Unit CRS Palo Alto, California, United States
  • UCSD Antiviral Research Center CRS San Diego, California, United States
View all 18 locations
View Trial Details
Completed

A Prospective, Randomized, Open-Label, Comparative Trial of Dideoxyinosine (ddI) Versus Dideoxycytidine (ddC) in HIV-Infected Patients Who Are Intolerant of or Who Have Failed Zidovudine (AZT) Therapy

NCT00000969

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • Community Consortium of San Francisco San Francisco, California, United States
  • Denver CPCRA / Denver Public Hlth Denver, Colorado, United States
  • Hill Health Corp New Haven, Connecticut, United States
  • Wilmington Hosp / Med Ctr of Delaware Wilmington, Delaware, United States
View all 16 locations
View Trial Details
Completed

A Phase I Concentration-Controlled Trial to Assess the Safety, Tolerance, Pharmacokinetics and Development of Decreased HIV-1 Susceptibility to the Combination of Atevirdine Mesylate (U-87201E), Zidovudine (AZT), and Didanosine (ddI)

NCT00000742

Conditions
AIDS-Related Complex, Acquired Immunodeficiency Syndrome, Blood-Borne Infections, +14 more
Locations
  • USC CRS Los Angeles, California, United States
  • Univ. of Miami AIDS CRS Miami, Florida, United States
  • Washington U CRS St Louis, Missouri, United States
  • Univ. of Rochester ACTG CRS Rochester, New York, United States
View Trial Details
Completed

A Randomized, Double-Blind, Four-Arm Study Comparing Combination Nucleoside, Alternating Nucleoside, and Triple-Drug Therapy for the Treatment of Advanced HIV Disease (CD4 <= 50/mm3)

NCT00000781

Conditions
Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +13 more
Locations
  • Univ of Alabama at Birmingham Birmingham, Alabama, United States
  • Children's Hosp of Los Angeles Los Angeles, California, United States
  • Univ of Southern California / LA County USC Med Ctr Los Angeles, California, United States
  • Huntington Memorial Hosp / Children's Hosp of Los Angeles Pasadena, California, United States
View all 96 locations
View Trial Details

Related conditions